LFCO human leukocyte sequence-specific oligonucleotide probe typing reagent - Taiwan Registration c11e82e9750b14e777b6af4432500453
Access comprehensive regulatory information for LFCO human leukocyte sequence-specific oligonucleotide probe typing reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c11e82e9750b14e777b6af4432500453 and manufactured by GEN-PROBE TRANSPLANT DIAGNOSTICS, INC.. The authorized representative in Taiwan is METEK LAB INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Does this product utilize polymerization? The chain reaction method was used to detect the presence or absence of human leukocyte antigens A, B, and C with a Luminex fluorescence analyzer.
B Hematology, pathology, and genetics
B.0001 Human leukocyte antigen typing test system
import
Dates and Status
Jun 26, 2013
Jun 26, 2018
Jul 21, 2016
Cancellation Information
Logged out
่ช่ซ่จป้ท